Ozempic and Other GLP-1 Drugs May Cut Cancer Risk

New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.

Ozempic and Wegovy Linked to Rare Blindness Risk, Study Finds

New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.

Next Gen Weight Loss Drugs Are Coming for Ozempic’s Throne

Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.

Hey Teens, No Obesity Meds for You, Experts Say

Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.

The Truth About Ozempic and Muscle Loss

Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us?

Here’s What Happens to People Who Stay on Wegovy Long Term

The results of the longest-running trial of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are here and looking positive.

Most People Who Stop Taking Wegovy/Ozempic Keep the Weight Off, Study Finds

More than a third of former semaglutide regained their shed pounds, however.

Wegovy and Other New Weight Loss Drugs Actually Work—so What’s Next?

Semaglutide and other new drugs are the real deal in obesity treatment, but there are many lingering questions about their future.

Latest Obesity Drug Really Does Keep the Weight Off—If You Keep Taking It

People who stopped taking Zepbound (tirzepatide) regained much of their lost weight within a year, while those on it kept losing more.

FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

In clinical trials, Eli Lilly's tirzepatide was found to help people lose upwards of 20% of their weight in conjunction with diet and exercise.

Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

People who already lost weight at first went on to shed substantially more pounds than those on a placebo, Eli Lilly's newest clinical trial found.

Obesity Drug Wegovy Found to Prevent Heart Attacks, Strokes in Major Trial

According to Novo Nordisk, people on Wegovy were 20% less likely to develop serious cardiovascular problems for up to five years when compared to placebo.

Experts Recommend Drugs, Surgery for Teen Obesity in New Guidelines

The American Academy of Pediatrics' guidelines are the first to emphasize proactive measures for treating childhood obesity, which has risen in recent years.

Weight Loss Surgery Reduces Cancer Risk, Study Finds

Over a 10-year period, patients who underwent bariatric surgery were far less likely to develop any cancer and more likely to survive it if they did.

Looking to Slim Down, Noom Lays Off Nearly 500 Wellness Coach Staff

The layoffs are a sign of struggle for an app that surged during the pandemic but has caught flak for dubious fitness goals.

More Evidence That People Eat More When They Sleep Less

In a new study, people who slept over an hour more than usual ate fewer calories per day.

UK Scientists Are Testing a New, Minimally Invasive Weight Loss Surgery

Left gastric artery embolisation is supposed to work by reducing the production of the so-called hunger hormone, ghrelin.

No Strong Evidence Supplements Do Anything for Weight Loss, Large Review Finds

Of the few decent studies that found some benefit from supplements, there were only small improvements.

A Weight Loss Aid That Makes Your Stomach Full With Less Food Just Cleared the FDA

FTC Rules Against Fake Amazon Reviews in Landmark Case